Specific targeting highly conserved residues in the HIV-1 reverse transcriptase primer grip region. Design, synthesis, and biological evaluation of novel, potent, and broad spectrum NNRTIs with antiviral activity.
about
Structure-based methods for predicting target mutation-induced drug resistance and rational drug design to overcome the problemLersivirine, a Nonnucleoside Reverse Transcriptase Inhibitor with Activity against Drug-Resistant Human Immunodeficiency Virus Type 12-Hy-droxy-N-(3-nitro-phen-yl)benzamide.5-Chloro-2-hy-droxy-benzoic acid.New in silico and conventional in vitro approaches to advance HIV drug discovery and design.Extensive mutagenesis of the conserved box E motif in duck hepatitis B virus P protein reveals multiple functions in replication and a common structure with the primer grip in HIV-1 reverse transcriptaseMechanism of interaction of novel indolylarylsulfone derivatives with K103N and Y181I mutant HIV-1 reverse transcriptase in complex with its substrates.Novel diaryltriazines with a picolinonitrile moiety as potent HIV-1 RT inhibitors: a patent evaluation of WO2016059647(A2).Comparison of the non-nucleoside reverse transcriptase inhibitor lersivirine with its pyrazole and imidazole isomers.Site-directed Mutagenesis of Key Residues Unveiled a Novel Allosteric Site on Human Adenosine Kinase for Pyrrolobenzoxa(thia)zepinone Non-Nucleoside Inhibitors.
P2860
Q26829549-20CC7660-B462-4592-8EDE-DFDD3CDB6883Q27663609-6239B716-73E5-4CC1-AA05-1A76D608807EQ34430764-9E5F183C-5A6B-441F-AA16-91CF8B6989AFQ34435345-39C8B497-745B-4974-BD32-D2779636AB14Q34483539-28DD79C3-0831-4B63-87D3-6D57C89D6DC0Q36086762-0021ECEE-83DA-4DFE-A75F-F69363F20BF6Q39290873-54891186-E7FE-4485-A038-C728B26E3584Q40447961-79AD07E5-7A8F-48CD-8BD0-F210829B4D03Q54610020-BCFC8DFC-45D0-4F8A-97F0-7FD86B28CAADQ55051342-90700AF7-BF9A-4827-980D-34A71DCA404E
P2860
Specific targeting highly conserved residues in the HIV-1 reverse transcriptase primer grip region. Design, synthesis, and biological evaluation of novel, potent, and broad spectrum NNRTIs with antiviral activity.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Specific targeting highly cons ...... NRTIs with antiviral activity.
@en
Specific targeting highly cons ...... NRTIs with antiviral activity.
@nl
type
label
Specific targeting highly cons ...... NRTIs with antiviral activity.
@en
Specific targeting highly cons ...... NRTIs with antiviral activity.
@nl
prefLabel
Specific targeting highly cons ...... NRTIs with antiviral activity.
@en
Specific targeting highly cons ...... NRTIs with antiviral activity.
@nl
P2093
P50
P356
P1476
Specific targeting highly cons ...... NRTIs with antiviral activity.
@en
P2093
Alberto Bergamini
Anna Ramunno
Giovanni Greco
Giovanni Maga
Giuseppe Campiani
Isabella Fiorini
Massimo Coletta
Meri De Angelis
Paul Huleatt
Silvio Spadari
P304
P356
10.1021/JM050257D
P407
P50
P577
2005-11-01T00:00:00Z